HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[WHO classification of tumours of the CNS: revised edition of 2007 with critical comments on the typing und grading of common-type diffuse gliomas].

Abstract
The fourth edition of the WHO classification of tumours of the CNS was published in 2007. Six new entities were codified: angiocentric glioma (AG); papillary glioneuronal tumour (PGNT); rosette-forming glioneuronal tumour of the fourth ventricle (RGNT); papillary tumour of the pineal region (PTPR); spindle cell oncocytoma of the adenohypophysis (SCO); and pituicytoma. Furthermore, six histological variants of well-known brain tumours have been added, partially because they show different biological behaviour and/or prognosis: pilomyxoid astrocytoma; atypical choroid plexus papilloma; medulloblastoma with extensive nodularity; anaplastic medulloblastoma; extraventricular neurocytoma; non-specific variant of dysembryoplastic neuroepithelial tumour (DNT). The new entities and variants are discussed in this review. Moreover, the typing und grading of common-type diffuse gliomas, as well as the WHO grading system, are critically reviewed, particularly with regard to the prognostically important differential diagnosis of diffuse astrocytomas und oligodendrogliomas.
AuthorsS Feiden, W Feiden
JournalDer Pathologe (Pathologe) Vol. 29 Issue 6 Pg. 411-21 (Nov 2008) ISSN: 1432-1963 [Electronic] Germany
Vernacular TitleWHO-Klassifikation der ZNS-Tumoren: Revidierte Fassung von 2007 mit kritischen Anmerkungen zum "Typing" und "Grading" diffuser Gliome.
PMID18820922 (Publication Type: English Abstract, Journal Article)
Topics
  • Astrocytoma (classification, pathology)
  • Brain Neoplasms (classification, pathology)
  • Central Nervous System Neoplasms (classification, pathology)
  • Choroid Neoplasms (classification, pathology)
  • Glioma (classification, pathology)
  • Humans
  • Medulloblastoma (classification, pathology)
  • Oligodendroglioma (classification, pathology)
  • Papilloma (classification, pathology)
  • World Health Organization

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: